News & Updates
Filter by Specialty:

Fremanezumab eases migraine and depressive symptoms
13 Jul 2023
byElvira Manzano
Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.